Rituximab-associated HBV Reactivation in Lymphoma Patients with Resolved Hepatitis B: Kinetics of Anti-HBs Titers with or without Entecavir Prophylaxis

被引：0
|
作者：
Huang, Yi-Hsiang [1 ,2 ]
Lee, I-Cheng [1 ,2 ]
Hsiao, Liang-Tsai [3 ]
Lin, Han-Chieh [1 ]
Lee, Shou-Dong [4 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan
[4] Cheng Hsin Gen Hosp, Taipei, Taiwan
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
932
引用
收藏
页码：652A / 652A
页数：1
相关论文
共 50 条
  • [41] Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma
    Abramson, Jeremy S.
    Chung, Raymond T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (23): : 2505 - 2507
  • [42] HIGH RATES OF HEPATITIS B VIRUS (HBV) FLARE AND REACTIVATION AMONG PATIENTS WITH CHRONIC INACTIVE HBV AND PRIOR RESOLVED HBV INFECTION TREATED WITH RITUXIMAB
    Junus, K.
    Aguilar, M.
    Patel, P.
    Irwin, D.
    Yee, S.
    Liu, B.
    Bhuket, T.
    Wong, R.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S376 - S376
  • [43] Long-term persistence of hepatitis B virus (HBV) in liver transplanted patients under anti-HBS immunoglobulins (HBIG).
    Virot, V
    Samuel, D
    Feray, C
    Gigou, M
    Roche, B
    Arulnaden, JL
    Bismuth, H
    HEPATOLOGY, 1996, 24 (04) : 1167 - 1167
  • [44] Anti-HBS and HBsAg kinetics during the first days after liver transplantation in patients receiving hepatitis B immune globulin for HBV reinfection prophylaxis: Evidence for an early accelerated administration scheme.
    Rosenau, J
    Tillmann, HL
    Wedemeyer, H
    Tietge, UJ
    Bahr, MJ
    Trautwein, C
    Boeker, KH
    Nashan, B
    Kuse, ER
    Klempnauer, J
    Manns, MP
    HEPATOLOGY, 2001, 34 (04) : 363A - 363A
  • [45] Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma
    Loglio, Alessandro
    Vigano, Mauro
    Grossi, Glenda
    Labanca, Sara
    Goldaniga, Maria
    Pompa, Alessandra
    Farina, Lucia
    Rumi, Mariagrazia
    Corradini, Paolo
    Facchetti, Floriana
    Lunghi, Giovanna
    Baldini, Luca
    Lampertico, Pietro
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (03) : 419 - 424
  • [46] Low risk of hepatitis B virus reactivation in membranous nephropathy patients with resolved infection undergoing rituximab-based regimens without antiviral prophylaxis
    Song, Dongxu
    Guo, Yanhong
    Wang, Yulin
    Tang, Lin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 139
  • [47] Risk of Hepatitis B Virus (HBV) Reactivation and Efficacy of Antiviral Preemptive Therapy in Malignant Lymphoma Patients Who Have Resolved HBV
    Maeda, Takeshi
    Ueda, Tomoaki
    Jo, Tomoyasu
    Okada, Kazuya
    Arai, Yasuyuki
    Kawata, Takahito
    Ito, Takeshi
    Morita, Satoko
    Onishi, Tatsuhito
    Mizutani, Chisato
    Matsuyama, Fumio
    Ueda, Yasunori
    BLOOD, 2009, 114 (22) : 1140 - 1140
  • [48] Post-Autotransplant Hepatitis B Virus (HBV) Reactivation in Lymphoma and Multiple Myeloma Patients with Hepatitis B Surface Antigen-Positive or Resolved HBV Infection
    Jang, Jieun
    Park, Hyunsung
    Lee, Jungyeon
    Kim, Yundeok
    Kim, Soo Jeong
    Cheong, June-Won
    Min, Yoo Hong
    Kim, Jin Seok
    BLOOD, 2014, 124 (21)
  • [49] Risk of Hepatitis B Virus (HBV) Reactivation and Role of Anti-Viral Prophylaxis in Lymphoma Patients with Past HBV Infection (HBV Antigen negative but anti-Hepatitis B core antibody positive) Receiving Chemo-Immunotherapy.
    Koo, Yu Xuan
    Tan, Shao Weng
    Tan, Bee Huat
    Tao, Miriam
    Chow, Wan Cheng
    Lim, Soon Thye
    BLOOD, 2008, 112 (11) : 1290 - 1290
  • [50] Reactivation of Hepatitis B Virus (HBV) Associated with Rituximab Use in Lymphoma: Under Reporting and Lack of Data Quality Reported to the FDA
    Evens, Andrew M.
    Fintel, Bara
    Chiu, Brian
    Gordon, Leo I.
    Ganger, Daniel
    Kulik, Laura
    Bennett, Charles L.
    BLOOD, 2009, 114 (22) : 557 - 558
12345